Compare SUVEN LIFE with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES ALEMBIC PHARMA SUVEN LIFESCIENCES/
ALEMBIC PHARMA
 
P/E (TTM) x 20.4 15.9 127.9% View Chart
P/BV x 4.1 4.0 104.2% View Chart
Dividend Yield % 0.5 1.0 53.1%  

Financials

 SUVEN LIFESCIENCES   ALEMBIC PHARMA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
ALEMBIC PHARMA
Mar-19
SUVEN LIFESCIENCES/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs338664 50.9%   
Low Rs169412 41.1%   
Sales per share (Unadj.) Rs52.1208.7 25.0%  
Earnings per share (Unadj.) Rs6.831.0 22.0%  
Cash flow per share (Unadj.) Rs8.637.1 23.1%  
Dividends per share (Unadj.) Rs1.505.50 27.3%  
Dividend yield (eoy) %0.61.0 57.9%  
Book value per share (Unadj.) Rs65.3144.2 45.3%  
Shares outstanding (eoy) m127.28188.52 67.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.6 188.6%   
Avg P/E ratio x37.117.4 213.8%  
P/CF ratio (eoy) x29.614.5 204.0%  
Price / Book Value ratio x3.93.7 104.1%  
Dividend payout %22.017.7 123.8%   
Avg Mkt Cap Rs m32,272101,461 31.8%   
No. of employees `0001.1NA-   
Total wages/salary Rs m6617,467 8.9%   
Avg. sales/employee Rs Th6,132.2NM-  
Avg. wages/employee Rs Th611.1NM-  
Avg. net profit/employee Rs Th803.5NM-  
INCOME DATA
Net Sales Rs m6,63539,347 16.9%  
Other income Rs m24294 258.3%   
Total revenues Rs m6,87739,441 17.4%   
Gross profit Rs m1,6048,736 18.4%  
Depreciation Rs m2211,152 19.2%   
Interest Rs m38184 20.5%   
Profit before tax Rs m1,5877,493 21.2%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7181,568 45.8%   
Profit after tax Rs m8695,844 14.9%  
Gross profit margin %24.222.2 108.9%  
Effective tax rate %45.220.9 216.2%   
Net profit margin %13.114.9 88.2%  
BALANCE SHEET DATA
Current assets Rs m6,23219,577 31.8%   
Current liabilities Rs m1,49014,896 10.0%   
Net working cap to sales %71.511.9 600.7%  
Current ratio x4.21.3 318.2%  
Inventory Days Days8690 96.3%  
Debtors Days Days8345 182.1%  
Net fixed assets Rs m4,04327,097 14.9%   
Share capital Rs m127377 33.8%   
"Free" reserves Rs m8,18326,811 30.5%   
Net worth Rs m8,31027,188 30.6%   
Long term debt Rs m184,993 0.4%   
Total assets Rs m10,38947,778 21.7%  
Interest coverage x43.141.7 103.4%   
Debt to equity ratio x00.2 1.2%  
Sales to assets ratio x0.60.8 77.6%   
Return on assets %8.712.6 69.2%  
Return on equity %10.521.5 48.7%  
Return on capital %19.523.6 82.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62219,453 28.9%   
Fx outflow Rs m1,7996,065 29.7%   
Net fx Rs m3,82213,388 28.6%   
CASH FLOW
From Operations Rs m3568,120 4.4%  
From Investments Rs m-279-7,556 3.7%  
From Financial Activity Rs m-225590 -38.1%  
Net Cashflow Rs m-1481,153 -12.9%  

Share Holding

Indian Promoters % 63.4 74.1 85.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.9 -  
FIIs % 0.0 9.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 13.9 262.6%  
Shareholders   37,287 49,328 75.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  BIOCON   J.B.CHEMICALS  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Flat; L&T and Tech Mahindra Top Losers(12:30 pm)

Share markets in India are presently trading on a volatile note. Sectoral indices are trading mixed with stocks in the capital goods sector and realty sector.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Nov 13, 2019 01:01 PM

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS